Clinical trial
Fenfluramine in CKDL5 Deficiency Disorder (CDD)
NCT03861871 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fenfluramine in CKDL5 Deficiency Disorder (CDD)
- Lead sponsor
- NYU Langone Health
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 29, 2019
- Completion date
- October 24, 2022
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cdd